SMAD7 抗体
(SMAD, Mothers Against DPP Homolog 7 (SMAD7))
The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SMAD7 抗体 (AA 1-100) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 160-260) | 人 | 小鼠 Monoclonal |
|
|
|
| SMAD7 抗体 (AA 160-260) | 人 | 小鼠 Monoclonal |
|
|
|
| SMAD7 抗体 (AA 195-224) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 160-260) | 人 | 小鼠 Monoclonal |
|
|
|
| SMAD7 抗体 (AA 302-400) | 人 | 小鼠 Monoclonal |
|
|
|
| SMAD7 抗体 (AA 195-224) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 36-247) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 49-317) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (N-Term) | 人, 大鼠, 猴 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 24-73) | 人, 大鼠, 猴 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (pSer249) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 160-260) | 人 | 小鼠 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 302-400) | 人 | 小鼠 Monoclonal |
|
|
|
| SMAD7 抗体 (AA 1-100) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 1-100) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 1-100) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 1-100) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| SMAD7 抗体 (AA 1-100) (FITC) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
3 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1G10
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 160-260
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3E9
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 160-260
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB18598
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 195-224
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4C11
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 160-260
Primary Antibody
- IF (Immunofluorescence: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3A11
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 302-400
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 195-224
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 36-247
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 49-317
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer249
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 160-260
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3A12
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 302-400
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Latest Publications for our SMAD7 抗体
: "Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis." in: Gastroenterology, Vol. 156, Issue 3, pp. 692-707.e7, (2019) (PubMed).
: "MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7." in: Molecular medicine reports, Vol. 15, Issue 6, pp. 3699-3705, (2017) (PubMed).
: "Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo." in: Frontiers in pharmacology, Vol. 8, pp. 929, (2017) (PubMed).
: "Transforming growth factor-β1 SMAD effectors and medial cell number in ascending aorta diseases." in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Vol. 25, Issue 3, pp. 240-6, (2016) (PubMed).
: "Acetyl-11-Keto-β-Boswellic Acid Attenuates Prooxidant and Profibrotic Mechanisms Involving Transforming Growth Factor-β1, and Improves Vascular Remodeling in Spontaneously Hypertensive Rats." in: Scientific reports, Vol. 6, pp. 39809, (2016) (PubMed).
: "Synchronous alteration pattern between serine-threonine kinase receptor-associated protein and Smad7 in pilocarpine-induced rats of epilepsy." in: Synapse (New York, N.Y.), Vol. 68, Issue 6, pp. 275-82, (2014) (PubMed).
: "MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy." in: Journal of diabetes research, Vol. 2014, pp. 918396, (2014) (PubMed).
: "Retinoic acid induced repair in the lung of adult hyperoxic mice, reducing transforming growth factor-β1 (TGF-β1) mediated abnormal alterations." in: Acta histochemica, Vol. 116, Issue 5, pp. 810-9, (2014) (PubMed).
: "A critical role for the mTORC2 pathway in lung fibrosis." in: PLoS ONE, Vol. 9, Issue 8, pp. e106155, (2014) (PubMed).
: "TGF-? induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer." in: Genes & cancer, Vol. 5, Issue 9-10, pp. 320-36, (2014) (PubMed).
: "MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7." in: Molecular medicine reports, Vol. 15, Issue 6, pp. 3699-3705, (2017) (PubMed).
: "Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo." in: Frontiers in pharmacology, Vol. 8, pp. 929, (2017) (PubMed).
: "Transforming growth factor-β1 SMAD effectors and medial cell number in ascending aorta diseases." in: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, Vol. 25, Issue 3, pp. 240-6, (2016) (PubMed).
: "Acetyl-11-Keto-β-Boswellic Acid Attenuates Prooxidant and Profibrotic Mechanisms Involving Transforming Growth Factor-β1, and Improves Vascular Remodeling in Spontaneously Hypertensive Rats." in: Scientific reports, Vol. 6, pp. 39809, (2016) (PubMed).
: "Synchronous alteration pattern between serine-threonine kinase receptor-associated protein and Smad7 in pilocarpine-induced rats of epilepsy." in: Synapse (New York, N.Y.), Vol. 68, Issue 6, pp. 275-82, (2014) (PubMed).
: "MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy." in: Journal of diabetes research, Vol. 2014, pp. 918396, (2014) (PubMed).
: "Retinoic acid induced repair in the lung of adult hyperoxic mice, reducing transforming growth factor-β1 (TGF-β1) mediated abnormal alterations." in: Acta histochemica, Vol. 116, Issue 5, pp. 810-9, (2014) (PubMed).
: "A critical role for the mTORC2 pathway in lung fibrosis." in: PLoS ONE, Vol. 9, Issue 8, pp. e106155, (2014) (PubMed).
: "TGF-? induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer." in: Genes & cancer, Vol. 5, Issue 9-10, pp. 320-36, (2014) (PubMed).
Aliases for SMAD7 抗体
SMAD family member 7 (SMAD7) 抗体SMAD family member 7 (Smad7) 抗体
SMAD family member 7 L homeolog (smad7.L) 抗体
SMAD family member 7 (smad7) 抗体
CRCS3 抗体
MADH7 抗体
Madh7 抗体
madh7 抗体
MADH8 抗体
Smad7a 抗体
Smad10 抗体
wu:fj60c10 抗体
xsmad7 抗体
您还需要查找其他产品吗？
- SMAD6 抗体
- SMAD5 抗体
- SMAD4 抗体
- SMAD2 抗体
- SMAD1 抗体
- SMAD, Mothers Against DPP Homolog 3 抗体
- SLX1A/GIYD2 抗体
- SLURP1 抗体
- SLUG 抗体
- SLU7 抗体
- SLTM 抗体
- SLPI 抗体
- SLN 抗体
- SLMO2 抗体
- SLK 抗体
- SLITRK6 抗体
- SLITRK5 抗体
- SLITRK4 抗体
- SLITRK3 抗体
- SLITRK2 抗体
- SMAD9 抗体
- SMAGP 抗体
- Small Cajal Body-Specific RNA 22 抗体
- Small Nuclear Ribonucleoprotein Polypeptide A 抗体
- Small Nuclear Ribonucleoprotein Polypeptide E 抗体
- Small Nuclear RNA Activating Complex, Polypeptide 1, 43kDa 抗体
- Small Ubiquitin Related Modifier 3 抗体
- Small Ubiquitin Related Modifier Protein 1 抗体
- SMAP2 抗体
- SMARCA1 抗体
- SMARCA2 抗体
- SMARCA4 抗体
- SMARCA5 抗体
- SMARCAD1 抗体
- SMARCAL1 抗体
- SMARCB1 抗体
- SMARCC1 抗体
- SMARCC2 抗体
- SMARCD1 抗体
- SMARCD2 抗体
You are here:
